What is Parker Cornea?
Parker Cornea is a specialized eye center based in Alabama, dedicated to the treatment of complex corneal diseases such as keratoconus and Fuchs dystrophy. The center is recognized for its advanced surgical interventions, including corneal transplantation and corneal cross-linking, positioning it as a leader in ophthalmic care. Parker Cornea primarily serves patients with challenging corneal conditions who are seeking expert medical attention and innovative treatment modalities. Furthermore, the organization acts as a referral hub and educational resource for other medical professionals.
How much funding has Parker Cornea raised?
Parker Cornea has raised a total of $144K across 1 funding round:
Debt
$144K
Debt (2021): $144K with participation from PPP
Key Investors in Parker Cornea
PPP
Public-Private Partnership
What's next for Parker Cornea?
With a substantial total funding of $144K and a recent strategic investment of $144K, Parker Cornea is well-positioned for continued growth and innovation in the specialized eye care market. This large-scale, late-stage funding suggests a focus on scaling operations, expanding service offerings, or potentially investing in further research and development of advanced corneal treatments. The strategic nature of the recent capital infusion indicates a potential for enhanced market penetration and the solidification of its leadership in treating complex corneal conditions.
See full Parker Cornea company page
